Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
heart failure
Pharma
AZ puts kibosh on two studies of hyperkalemia med Lokelma
AstraZeneca has put the kibosh on two late-stage Lokelma trials testing the hyperkalemia drug in patients with heart and kidney diseases.
Fraiser Kansteiner
Dec 1, 2023 9:45am
In push to boost Kerendia, Bayer adds 3 heart failure trials
Sep 1, 2023 11:03am
Marlex pulls 2 batches of heart failure med after label snafu
Sep 1, 2023 9:02am
AZ's Dobber talks SGTL2, GLP-1 clash in heart failure
Aug 29, 2023 1:30pm
At ESC, AstraZeneca shows Farxiga's benefits across indications
Aug 28, 2023 10:10am
Novo's Wegovy posts trial win in patients with heart failure
Aug 25, 2023 8:45am